Suchergebnisse - "Farinati, Fabio"

PubPharm (471)

71

Determinants of increased thrombotic tendency in NASH cirrhosis : not there yet!

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2021

von Zanetto, A. | Senzolo, M. | Campello, E. | +9

CommentOn: Transpl Int. 2021 Jun;34(6):1105-1122. - PMID 33780554

72

A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer

enthalten in: Updates in surgery | 2021

von Tonello, A. | Capelli, G. | Bao, Q. | +6

73

A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer

enthalten in: Updates in surgery | 2021

von Tonello, A. | Capelli, G. | Bao, Q. | +6

74

A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer

enthalten in: Updates in surgery | 2021

von Tonello, A. | Capelli, G. | Bao, Q. | +6

75

Liver histopathology in COVID-19 patients : A mono-Institutional series of liver biopsies and autopsy specimens

enthalten in: Pathology, research and practice | 2021

von Fassan, M. | Mescoli, C. | Sbaraglia, M. | +11

76

Liquid Biopsy in Hepatocellular Carcinoma : Where Are We Now?

enthalten in: Cancers | 2021

von Pelizzaro, F. | Cardin, R. | Penzo, B. | +5

77

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

enthalten in: Liver cancer | 2021

von Campani, C. | Vitale, A. | Dragoni, G. | +26

78

Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma : Beyond Rigid Staging Systems Towards a More Personalized Therapeutic Approach

enthalten in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract | 2021

von Giannini, E. | Plaz Torres, M. | Vitale, A. | +3

CommentOn: J Gastrointest Surg. 2020 Dec;24(12):2737-2747. - PMID 31768830

79

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

enthalten in: Cancers | 2021

von Vitale, A. | Farinati, F. | Finotti, M. | +13

80

Circulating prostaglandin $ E_{2} $: a novel potential prognostic biomarker in patients with hepatocellular carcinoma

enthalten in: Clinical and experimental medicine | 2021

von Pelizzaro, F. | Kitenge, M. | Cardin, R. | +7